| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Clene Inc. | CNM-Au8 - (VISIONARY-MS) | Multiple Sclerosis | Phase 2 | Trial Completed | Oral | Neurology |
| Clene Inc. | CNM-Au8 - (HEALEY ALS) | Amyotrophic Lateral Sclerosis (ALS) | Phase 2/3 | Data Released | oral | Neurology |
| Clene Inc. | CNM-Au8 - (RESCUE-ALS) | Amyotrophic Lateral Sclerosis | Phase 2 | Data Released | Oral | Neurology |
| Climb Bio Inc. | Budoprutug (TNT119) | Systemic lupus erythematosus | Phase 2 | Ongoing | Intravenous | Immunology |
| Clyde Resources Inc | VTP-300 (HBV003) | Chronic HPV Infection | Phase 2b | Trial Completed | Intramuscular | Antiviral |
| Clyde Resources Inc | Imdusiran (AB-729 and VTP-300 with nivolumab) - (IM-PROVE I) | Hepatitis B (HBV) | Phase 2a | Data Released | Subcutaneous | Antiviral |
| Clyde Resources Inc | VTP-300 (HBV003) | Hepatitis B (HBV) | Phase 2b | Enrollment Conclusion | Intramuscular | Antiviral |
| CNS Pharmaceuticals Inc. | Berubicin | Glioblastoma (GBM) (adult) | Phase 2 | Enrollment Conclusion | Intravenous | Oncology |